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Multifactor Potency Scheme for
Comparing the Carcinogenic Activity of
Chemicals
by Stephen Nesnow*
Aschemeforrankingthequantitativeactivity ofchemicalcarcinogensisdescribed. Thisactivityschemeusesasitsbase
dose potency measuredasTI), whichafterconversion intoaninverse logscale, adecilescale, isadjusted by weighting
factorsthatdescribeotherparametersofcarcinogenicactivity. Thesefactorsincludepositiveornegativeweightingsfor
theinductionoftumosattissuesororgansassoiatedwithhighhistorkalcontroltumorincidences;theinductionoftumors
atmultiplesites;theinductionoftumorsinbothsexesofthespecies; andtheinductonoftumWSinmorethanonespecies.
Thesefactors werechosenbecausetheyrepresentedqualitativedescriptionsofthegeneralspecificity ornonspecificity
ofchemicalswithregardtotheactivityinrodentsandhavesomebearingonthepotentialactivityofceialsinhumans.
Tbconstructameasuretoexpresstheinactivityofchemicalstowardtheinductionofcancer,ameasureanaogoustothe
TD,. hasbeendeveloped: highestavenrgedailydose (HADD) inmilliganu chemical/kilogram bodyweightadminisered
inachroniccancerstudyandthatdidnotinduceastatistica increaseintumors.HADDvaluesweresimilarlyconverted
tologdecileunitsandadjustedbyweightingfactorsaccordingtolackofactivityinbothsexesofaspeciesandthelackof
activity inmorethanonespecies. Threeactivityrankingschemesweredeveloped: thecarcinogenactivity-F344rat, an
activityschemebasedoncancerdataobtained withtheF344rat;the nogenactivity-B6C3F, mouse, anactivity scheme
basedoncancerdataobtainedwiththeB6C3FI mouse, andthecarcinogenactivitycombined, anactivityschemebased
onselecting data fromboth theF344ratandB6C3F, mouse.
Introduction
Several models for estimating the carcinogenic activity of
chemicals have been proposed in which activity or potency is
described incombinations ofterms ofadministereddose, tumor
incidence, ortumorlatency (1-4). Whileeachofthese potency
models is useful, there is a need to develop a cancer activity
scheme thatincorporates other factors in addition todose in its
construct. These factors should account for the specificity or
nonspecificity ofchemicals with respecttotheability toinduce
cancer in more than one sex of an experimental test species as
well astheabilityofthechemical toinducetumorsin morethan
onetestspecies. Thesecharacteristics areparticularly important
iftheendpointofconcern isthepotentialofthatchemical toin-
duce cancerin man. Chemicals that arenonspecificwithregard
totumorsite, sex, andspeciesofexperimental animal are more
likely tobe apotential hazard to man. This is based onthe fact
that the majority of chemicals evaluated by the International
Agency for Research on Cancer (IARC) andrated as sufficient
evidence ofcarcinogenicity based on human data are also car-
cinogenic in experimental animals (5) and that most of these
humancarcinogens arealsohighly active as genetic toxins (6).
Therefore, it wasofinteresttointegratedose-response relation-
ships with factors that describe the generality or specificity of
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chemicalswithregard totargetspecies, sex, organs, andtissue
sites. A complete description ofthis work is found in Nesnow
(7).
Results
Inthiscancer-activity ranking scheme, thefollowing factors
were incorporated: an estimate of dose potency as the major
determinant; aweightingfortumorigenicresponsesinorgansor
tissues that have a low historical control tumor incidence; a
weighting for tumorigenic responses in multiple tissues or
organs; aweighting fortumorigenic responses inboth sexes of
the samespecies; andaweightingfortumorigenicresponsesin
multiple species.
Because dose potency would be the major determinant, the
method for applying the weightings was to directly adjust the
dosepotencyvalueafterconverting ittoalognumeric scale. In
applyingtheseweightings, it was necessary to selectabase in-
crementadjustmentvalue, andtheconceptofdoublingdosewas
employedforthispurpose(8). Therefore, weightingfactorsin-
creasing or decreasing the dose potency value ofchemicals by
factors of2 were established.
In constructing this activity scheme that compares the re-
sponsesofdifferentchemicals, itwasdesirabletocomparedata
generatedby administering chemicalsby the same route to the
same sexes, strain, and species of test animal. Comparisons
madebetweentheactivityofchemicalswouldthereforebemadeS. NESNOW
using a common setofvariables. It wasalsodesirabletousedata
derivedfromstandardizedprotocols, with standardizednumbers
ofanimals trreated, sufficient numbers oftissuesexamined, and
appropriatequality-control procedures. Therefore, inconstruc-
tion ofthis scheme, the National Toxicology Program/National
Cancer Institute (NTP/NCI) bioassay data (9-11) from diet,
water, orgavageroutesofadministrationtoF344ratsandB6C3Fj
mice wereused. Thiswouldallowthecreationoftwoindependent
canceractivityrankings, onebased ondatageneratedintheF344
ratandonebasedondatageneratedintheB6C3Flmouse,andeach
based on onegeneralizedrouteofadministration.
Fordose potency, theTD50data wereused (4,12). The selec-
tionofindividualTD50valuesfoundinGoldetal. (12)andearlier
references for each sex-species combination ofeach chemical
was predicated on three rules: a) Ifseveral TD50 values were
available for a sex-species combination, then the one with the
lowestvalue waschosen (themostsensitiveendpoint). b)Inthe
Gold et al. (12) reports, several TD50 values are calculated for
each chemical. OnlyTD5ovalueswith aprobability ofp < 0.05
were chosen. c) Only TD50 values were used for those studies
rated as positive in the NTP/NCI technical reports (9-11).
For those chemicals found to be inactive in a specific sex-
speciesthehighest averagedailydose(HADD) administered to
the testcombination, animals wasused as a measureofinactivity.
TheHADDvaluesinmilligramchemicaladministered/kilogram
body weight/day were calculated according to the methods de-
scribedby Goldetal. (12) fromthehighestdoseadministered as
describedintheNTP/NCITechnical Reports (9-11). Chemicals
that weretestedby theNTP/NCI intheF344 ratandtheB6C3FI
mouseby oral routes ofadministration and that were found not
toinduce tumorsinall foursex-speciescombinations werealso
includedwiththeirHADDvalues. Intotal, 142 chemicals were
selected. Table 1 lists some examples ofthese chemicals.
A log method was applied to the TD50 values and HADD
values to convert them into a numeric scale for comparisons
among chemicals. These converted TD50 values are termed
decile units and are inversely related to TD50 values by the
formula:
decile value (active chemical) = log[107/TD50]
Decilevaluesforactivechemicals (carcinogens) arepositiveand
range from >0 to 14.
A similar concept was used to convert the HADD values for
the inactive chemicals (noncarcinogens) with the formula:
decile value (inactive chemical) = -log[abs(HADD) x 103]
Decilevaluesforinactivechemicals arenegativeand rangefrom
<0 to -10. Decile values for individual sex-species com-
parisons for several ofthe 142 chemicals are found in Table 2.
Table 1. Examples ofchemicalsselected forcomparison andtheirTD5. values (forcarcinogens) orhighest average
daily dose (HADD) values (fornoncarcinogens).'
TD30 orHADD, mg/kg body weight/day
NTP/NCI
Technical Report F344 rat B6C3F mouse
Chemical name CAS number no. Male Female Male Female
Acetohexamide 968-81-0 50 -770 -963 -1526 -1653
Aldicarb 116-06-3 136 -0.24 -0.3 -0.72 -0.78
Allyl isothiocyanate 57-06-7 234 54.3 NAb -17.9 -17.9
2-Aminoanthraquinone 117-79-3 144 101 -70.9 755 1490
3-Animo-4-ethoxyacetanilide 17026-81-2 112 -414 -518 2070 -845
3-Amino-9-ethylcarbazole HCI 132-32-1 93 28.1 55.1 46.4 33
I-Amino-2-methylanthraquinone 82-28-0 111 34.1 115 -53.6 NA
4-Amino-2-nitrophenol 119-34-6 94 309 NA -294 -319
2-Amino-5-nitrothiazole 121-66-4 53 27.6 -29.7 -11.9 -12.8
aFrom Nesnow (7).
bNA, not applicable.
Table2. Examples ofthecalculation ofunadjustedandadjusted individual sex-species valuesforthemaleand femaleF344 rat
andB6C3FW mouse indecileunits.'
Individual sex-species value (decileunits)
Unadjusted Adjusted
F344 rat B6C3F1 mouse F344 rat B6C3F1 mouse
Chemical name Male Female Male Female Male Female Male Female
Acetohexamide -5.89 -5.98 -6.18 -6.22 -5.89 -5.98 -6.18 -6.22
Aldicarb -2.38 -2.48 -2.86 -2.89 -2.38 -2.48 -2.86 -2.89
Allyl isothiocyanate 5.27 NAb -4.25 -4.25 5.27 NA -4.25 -4.25
2-Aminoanthraquinone 5.00 -4.85 4.12 3.83 5.00 -4.85 3.82c 4.43d
3-Amino-4-ethoxyacetanilide -5.62 -5.71 3.68 -5.93 -5.62 -5.71 3.68 -5.93
3-Amino-9-ethylcarbazole HCI 5.55 5.26 5.33 5.48 6.45d 6.16d 5.03c 5.48
I-Amino-2-methylanthraquinone 5.47 4.94 -4.73 NA 6.37d 4.94 -4.73 NA
4-Amino-2-nitrophenol 4.51 NA -5.47 -5.50 4.51 NA -5.47 -5.50
2-Amino-5-nitrothiazole 5.56 -4.47 -4.08 -4.11 5.56 -4.47 -4.08 -4.11
'From Nesnow (7). Conversion ofTD50 values (from Table 1) into decile units.
bNA, not applicable.
cTheseTD50values indecileunits wereadjusted (-0.3 decileunits) forTD50valuesbasedsolelyontumorswithhighhistoricalcontrol tumorincidences (2 10%).
dThese TD50 values indecile units were adjusted (+0.9decileunits) for tumorsappearing at more thanoneorgan ortissue site.
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Themultifactor carcinogen activity scheme wasconstructed
to representtheactivityofchemicals withrespecttodoseandto
the induction oftumors at sites associated with low historical
control tumor incidence, the induction oftumors in more than
oneorganortissuesite, theinductionoftumors (orlackofinduc-
tionoftumors) inboth sexesofF344 ratsand/orB6C3F1 mice,
andinductionoftumors (orlackofinductionoftumors)inboth
F344 ratsandB6C3FI mice. Theindividual stepsinthisprocess
areoutlinedinFigure 1. Theproceduresusedateach stepinthe
calculations are described below.
Anadjustment tothedecilevalues foreach sex-species com-
binationwasmadetoaccountforthemagnitudeofthehistorical
controltumorincidencevaluesatthesitesofthetumorsusedin
thecalculationoftheTD50value. Adecrementof0.3decileunits
was appliedtotheTD50value indecileunits foreachsex-species
combination who TD50 value was based on tumors with an
associated historicalcontroltumorincidenceof>10% (13). This
had the effect ofdoublingthe TD50 value (Table 2).
Because chemicals thatinducetumors atmorethanoneorgan
ortissue siteareofmoreconcern, thedecilevaluesofthose sex-
species combinations exhibiting tumors at multiple organs or
tissues wereincreased. Thiswasaccomplishedbyincreasingthe
decile valueby 0.9 decile units forthose sex-species combina-
tionsthatdemonstrated astatistical increaseinbenignormalig-
nanttumorsatmorethanoneorganortissue siteasdescribed in
theNTP/NCItechnical reports (9-11) (Table2). Thisadjustment
had the effect ofreducing the TD50 value by a factor of8.
After calculating the four adjusted individual sex-species
values, we calculated the carcinogen activity-F344 rat andthe
carcinogenactivity-B6C3F, mouse values. For each chemical
tested, the male and female adjusted individual sex-species
values were compared to select the predominating adjusted in-
dividual sex-species value. This wasperformed foreachspecies.
Two rules were employed forthe selectionprocesses: apositive
valuetookprecedence overanegativevalueandahigherabsolute
numeric value took precedence over a lower absolute numeric
value. These rules had the effect ofselecting for the most sen-
sitive (fortumorigenicactivity) adjusted individual sex-species
value for active chemicals and the least sensitive (for toxicity)
sex-species combination for the inactive chemicals.
Afterselecting thepredominating sex-species valueforeach
species, a factor for activity (or inactivity) in both sexes (cor-
respondencebetween sexes) wasappliedtogivethecarcinogen
activity-F344 orthe carcinogen activity-B6C3F1 mouse, ifthe
chemical was tested in both sexes ofa species. A value of0.06
decile units was added tothepredominating adjusted individual
sex-species value if both sexes had adjusted individual sex-
species decilevaluesthatwerepositive(thechemical wasactive
in both sexes). A value if -0.6 decile units was added to the
predominating adjusted individual sex-species value if both
sexes had adjusted individual sex-species decile valuesthat were
negative (thechemical was inactive inboth sexes) (Table 3). This
procedure raisedtheabsolutenumericvalues ofthosechemicals
that had been tested in both sexes and that gave corresponding
results to yield the carcinogen activity-F344 rat or the car-
cinogenactivity-B6C3F1 mouse. Avalueof-0.54decileunits
was added to the predominating adjusted individual sex-species
value ifboth sexes had been tested and the adjusted individual
sex-species decile values were positive and negative (noncor-
respondencebetween sexes) (Table 3). Thethreefictorsused in
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FIGuRE 1. Stepstaken inthecalculationofthemultifactorcarcinogenactivity
schemevalues forchemicals. From Nesnow (7).
thesecalculations werederived as follows: Anoverall factorof
0.6decileunits wasselectedasthebaseunitandwasadjustedfor
theobservedhistoricalcorrespondencebetweenthetwosexesof
each species to chemical carcinogens. The historical cor-
respondencesbetweenthebothsexesofF344ratandtheB6C3F,
mouseareequivalent, 89.3%, basedona222-chemicaldataset
(9). Therefore, whenthedataareavailableforbothsexesofF344
ratsorB6C3F, mice, thefactorthatisappliedtotheresultsthat
are corresponding (both sexes positive) is 0.06 (0.6 x [1.0 -
0.893]). The factor applied to the predominating adjusted in-
dividual sex-species value for results that are conflicting (one
positive, onenegative) is0.54 (0.6 x 0.893).
The calculation ofa combined species activity (carcinogen
activity-combined) was performed in a similar fashion to the
calculation of the carcinogen activity-F344 rat and the car-
cinogen activity-B6C3F1 mouse. For each chemical, the car-
cinogen activity-F344 rat value and the carcinogen activity-
B6C3F1 mousevaluewerecomparedtoselectthepredominating
carcinogen activity species value using the following rules: a
positivevaluetookprecedenceoveranegativevalue, ahigherab-
solute numeric value took precedence over a lower absolute
numeric value.
Afterselectingthepredominatingcarcinogenactivityspecies
value for each chemical, a factor for activity (or inactivity) in
both species was applied to give the carcinogen activity-
combined. A value of 0.5 decile units was added to the pre-
19S. NESNOW
Thble3. Examples ofmultifactorcarcinogen-activity scalevaluesforNTP/NCIchemicals."
Carcinogenicactivity
Chemical name F344rat B6C3F, mouse Combined
Acetohexamide -6.58b -6.82 -8.32c
Aldicarb -2.98e 3.49b -49.9c
Allyl isothiocyanate 5.27 -4.85b 4.27d
2-Aminoanthraquinone 4.46e 4.49' 4.998
3-Amino-4-ethoxyacetanilide 56.31b Me 2.i5d
3-Amino-9-ethylcarbazole HCI 6.52' 5.55' 7.01j
I-Amino-2-methylanthraquinone 6.43' -4.73 5.43d
4-Amino-2-nitrophenol 4.51 -6.10" 3.51d
2-Amino-5-nitrothiazole 5.02e _4.71b 4.02d
aFrom Nesnow (7).
bA factorof-0.60decile units was added tothepredominatingadjusted individual sex-species valuetogivethis number.
CA factorof-1.50decile units was added tothepredominatingcarcinogenactivity-F344 ratorcarcinogenactivity-B6C3F, mousevalue togivethis number.
dAfactorof-1.00decile units wasaddedtothepredominatingcarcinogen activity-F344 ratorcarcinogenactivity-B6C3F, mouse valuetogivethis number.
'A factorof-0.54decile units wasaddedtothepredominating adjusted individual sex-speciesvaluetogivethisnumber.
'A factorof0.06decile uknits was addedtothepredominatingadjusted individual sex-species valuetogivethis number.
9A factorof0.50decile units was added tothepredominatingcarcinogen activity-F344 ratorcarcinogenactivity-B6C3F, mousevalue togive this number.
dominating carcinogen activity species decile value if both
specieshadcarcinogenactivitydecilevaluesthatwerepositive
(thechemicalwasactiveinbothspecies). Avalueof-1.5decile
units wasaddedtothepredominatingcarcinogenactivityspecies
decilevalueifbothspecieshadcarcinogenactivitydecilevalues
thatwerenegative (thechemical wasinactiveinbothspecies).
Avalueof -1.0decileunitswasaddedtothepredominatingcar-
cinogen activity species decile value ifboth species had been
tested and the carcinogen activity species decile values were
positive and negative (noncorrespondence between species)
(Table3). Thisprocedureraisedtheabsolutenumericvaluesof
thosechemicalsthathadbeentestedinbothspeciesandthatgave
correspondingresultstoyieldthecarcinogenactivity-combined.
Thevalueof1.5decilevaluewasselectedasthebaseunitandwas
adjusted based on the observed historical correspondence be-
tweentheF344ratandtheB6C3F, mouse(oneormoresexesof
eachspecieswereactiveand/orbothsexesofbothspecieswere
inactive), 66.7% (9). Therefore, whenthedataareavailablefor
both F344 rats and B6C3FI mice, the factor that is applied to
results thatarecorresponding (both sexespositive) is0.50 [1.5
x (1.0 - 0.667)]. The factor applied to the carcinogen activity
species value for results thatareconflicting (onepositive, one
negative) is 1.0 (1.5 x 0.667).
Discussion
The development of the multifactor carcinogen-activity
scheme is based on a number ofassumptions concerning the
relativeactivity ofchemicals. Theseincludethegeneralassump-
tionthatchemicalspositiveinmorethanonesexandmorethan
one species should be considered more potentthan chemicals
thatarenot. Inaddition, chemicalsthatproducetumorsinorgans
or tissues that are not associated with high historical control
tumorincidencesandchemicalsthatinducetumorsatmorethan
oneorgan ortissue site shouldalsobeconsidered morepotent
thanthosethatdonot. Basedontheseassumptions, themultifac-
torcaracinogen-activity schemehasbeendeveloped, whichin-
corporates allofthesepropertiesofachemicalintooneunified
basis forcomparison. Inthisscheme,theoverridingdeterminant
ofactivityisdose. Allofthepreviouslydescribedfactorsareused
asadjustmentstotheoriginaldosepotencyasdeterminedforthe
activechemicalsasTD5oorfortheinactivechemicalsasHADD.
The maximum adjustment to dose potency for two chemicals
(onethatinducestumorsatmultiplesites, isactiveinbothsexes
ofone species and also active in at leastone sex ofthe second
speciesandthesecondchemicalthatinducestumorsatonlyone
siteandisactiveinonesexofonespecies) isadecilevalueof3
(0.9 + 0.06 + 0.54 + 0.5 + 1.0) oradosefactorof1000.
Amajordecisioninderivingthisactivityschemewasthecon-
siderationofeitheraveragingorselectingtheindividualadjusted
sex-species decile values for calculating the carcinogen
activity-F344ratandthecarcinogenactivity-B6C3F1 mouseor
averagingorselectingthecarcinogenactivity-F344ratandthe
carcinogenactivity-B6C3F, mousetocalculatethecarcinogen
activity-combined. It was considered that for a carcinogen-
activityscheme, positivedecilevaluescouldbenotbeaveraged
withnegativedecilevaluesasthismightresultinactivechemi-
calsbeingclassifiedasinactive. Alsoconsideredwasthatanac-
tivechemicalthathadtwodissimilarsexorspeciesdecilevalues
(innumericterms)shouldberepresentedintermsofitsmostsen-
sitiveindicator(i.e., thelowestTD50value). Similarly,forinac-
tive chemicals, the least sensitive HADD value was selected,
whichrepresentedthehigherofthetwodoselevelsadministered
(theleasttoxicchemical). Theimpactontheselectionprocess
resulting from the rat being generally more sensitive than the
mouse to the tumorigenic effects ofchemicals is that the car-
cinogen activity-F344 rat was selected over the carcinogen
activity-B6C3F, mouse in the calculation of the carcinogen
activity-combined. Becausethemouseisgenerallylesssensitive
thantherattothetoxiceffectsofchemicals, asevidencedbythe
HADD values, the carcinogen activity-B6C3F1 mouse was
generally'selected overthecarcinogen activity-F344 rat. The
observationthatthemouseisgenerallylesssensitivethantherat
tothecarcinogenicandtoxiceffectsofchemicalsmaybedueto
the protocol used by the NCI/NTP, which uses the maximum
tolerateddoseas thebasisfordose selection.
In the future, this multifactor carcinogen-activity scheme
couldbemodifiedinseveral ways. Thevaluesassignedtoeach
ofthefactorscouldbealteredtoreflectadifferentemphasis. Ad-
ditional factors couldbeincorporated into the scheme such as
weightings formalignanttumorsandweightings forthepresence
ofspecificmetabolic,pharmacokinetic, and/orDNAadductdata
thatrelateresultsinexperimentalanimalstoman. Theselection
oftheF344ratandtheB6C3F1 mouseasthetestanimalsandthe
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oral routesasthestandardroutesofexposureplacesarestriction
ontheuseoflargerdatabases suchasthe "SurveyofChemicals
which HaveBeenTestedforCarcinogenicActivity" (14)orthe
U.S.Environmental ProtectionAgency'sGene-ToxCarcinogen
DataBase(15). Theserestrictions couldbeliftedunderspecial
circumstances toincludestrainsofratsandmiceotherthanF344
rats andB6C3Fj mice and routes ofadministration other than
oral.
The multifactor carcinogen-activity scheme presented here
represents aninitial effort in an investigationofmethods need-
edtoassess thepotential riskofchemicals. Itishopedthatthis
effortwillcatalyzeotherinvestigators intosimilarinvestigations
towards modifying and improving the original concept
presented. Thereisapressingneedformethodsthatcanesimate
theinherentcarcinogenicactivityofchemicals andawidepoten-
tial useforthesemethodswithapplications inboththeresearch
and risk assessment areas.
Theresearchdescribed inthisarticlehasbeenreviewedbytheHealthEffects
Research Laboratory, U.S. Environmental ProtectionAgency, andapprovedfor
publication. Approval does notsignify thatthe contents necessarily reflectthe
viewsandpoliciesoftheAgency andnoofficial endorsementshouldbeinferred.
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